Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.

Horváth B, Mukhopadhyay P, Haskó G, Pacher P.

Am J Pathol. 2012 Feb;180(2):432-42. doi: 10.1016/j.ajpath.2011.11.003. Epub 2011 Dec 5. Review.

2.

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.

Di Marzo V, Piscitelli F, Mechoulam R.

Handb Exp Pharmacol. 2011;(203):75-104. doi: 10.1007/978-3-642-17214-4_4. Review.

PMID:
21484568
3.

Cannabinoids.

Grotenhermen F.

Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review.

PMID:
16266285
4.

[News about therapeutic use of Cannabis and endocannabinoid system].

Duran M, Laporte JR, Capellà D.

Med Clin (Barc). 2004 Mar 20;122(10):390-8. Review. Spanish.

PMID:
15033046
5.

Role of the endocannabinoid system in diabetes and diabetic complications.

Gruden G, Barutta F, Kunos G, Pacher P.

Br J Pharmacol. 2016 Apr;173(7):1116-27. doi: 10.1111/bph.13226. Epub 2015 Aug 20. Review.

6.

The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.

7.

Cannabinoids, endocannabinoids, and cancer.

Hermanson DJ, Marnett LJ.

Cancer Metastasis Rev. 2011 Dec;30(3-4):599-612. doi: 10.1007/s10555-011-9318-8. Review.

8.

Modulating the endocannabinoid system in human health and disease--successes and failures.

Pacher P, Kunos G.

FEBS J. 2013 May;280(9):1918-43. doi: 10.1111/febs.12260. Epub 2013 Apr 22. Review.

9.

Cannabinoids and the gut: new developments and emerging concepts.

Izzo AA, Sharkey KA.

Pharmacol Ther. 2010 Apr;126(1):21-38. doi: 10.1016/j.pharmthera.2009.12.005. Epub 2010 Feb 1. Review.

PMID:
20117132
10.

The endocannabinoid system: physiology and pharmacology.

Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M.

Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. Epub 2004 Nov 18. Review.

PMID:
15550444
11.

Psychopharmacology of the endocannabinoids: far beyond anandamide.

Pamplona FA, Takahashi RN.

J Psychopharmacol. 2012 Jan;26(1):7-22. doi: 10.1177/0269881111405357. Epub 2011 Jun 7. Review.

PMID:
21652605
12.

The endocannabinoid system as a target for the treatment of motor dysfunction.

Fernández-Ruiz J.

Br J Pharmacol. 2009 Apr;156(7):1029-40. doi: 10.1111/j.1476-5381.2008.00088.x. Epub 2009 Feb 13. Review.

13.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
14.

Cannabinoids, endocannabinoids, and related analogs in inflammation.

Burstein SH, Zurier RB.

AAPS J. 2009 Mar;11(1):109-19. doi: 10.1208/s12248-009-9084-5. Epub 2009 Feb 6. Review.

15.

Plant, synthetic, and endogenous cannabinoids in medicine.

Di Marzo V, Petrocellis LD.

Annu Rev Med. 2006;57:553-74. Review.

PMID:
16409166
16.

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R.

Trends Pharmacol Sci. 2009 Oct;30(10):515-27. doi: 10.1016/j.tips.2009.07.006. Epub 2009 Sep 2. Review. Erratum in: Trends Pharmacol Sci. 2009 Dec;30(12):609.

PMID:
19729208
17.

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

McPartland JM, Duncan M, Di Marzo V, Pertwee RG.

Br J Pharmacol. 2015 Feb;172(3):737-53. doi: 10.1111/bph.12944. Review.

18.

The emerging role of the endocannabinoid system in endocrine regulation and energy balance.

Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R.

Endocr Rev. 2006 Feb;27(1):73-100. Epub 2005 Nov 23. Review.

PMID:
16306385
19.

Cannabinoid receptors as therapeutic targets.

Mackie K.

Annu Rev Pharmacol Toxicol. 2006;46:101-22. Review.

PMID:
16402900
20.

The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Scotter EL, Abood ME, Glass M.

Br J Pharmacol. 2010 Jun;160(3):480-98. doi: 10.1111/j.1476-5381.2010.00735.x. Review.

Supplemental Content

Support Center